InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: BonelessCat post# 100372

Sunday, 05/03/2015 9:07:54 PM

Sunday, May 03, 2015 9:07:54 PM

Post# of 403091
How am I failing to be clear? Look at the Aprea Apr246 data. They show survival curves for refractory ovarian ca treatment with cisplat plus apr246. That is what CTIX needs to show for K, not to mention all the other data for all the other very difficult to treat cancers that are out there begging for some effective intervention. The future of K is adding value to other therapies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News